Share this
Origin to List on Nasdaq via SPAC Merger With Artius
Castle Biosciences $74 Million IPO
Atlassian - $531 Million IPO
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
Cidara Completes Initial Public Offering
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
Bellicum Pharmaceuticals $160 million IPO
Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes
Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes
Measurabl Series A and Series B Financings
Bionano Genomics Initial Public Offering